Orion Infusion Limited announced un-audited earnings results for the third quarter and nine months ended March 31, 2018. The company reported EPS was BDT 0.24 for January-March 2018 as against BDT 0.46 for January-March 2017. The company reported EPS was BDT 1.03 for July 2017-March 2018 as against BDT 1.14 for July 2016-March 2017. NOCFPS was BDT 0.02 for July 2017-March 2018 as against BDT 0.92 for July 2016-March 2017. NAV per share was BDT 12.13 as on March 31, 2018 and BDT 12.57 as on June 30, 2017.